ABCB5 and neoplasm: In addition, heterogeneous expression of various markers (such as ABCB5, NGFR, CD54, KIT, etc.)has been identified in tumour samples, although there are no significant differences in the tumourigenicity or metastatic properties of the subpopulations with differing expression [93,94].